Pomalidomide
CC-4047-MM-011
Phase 2 small_molecule completed
Quick answer
Pomalidomide for Multiple Myeloma is a Phase 2 program (small_molecule) at Celgene Europe Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Celgene Europe Limited
- Indication
- Multiple Myeloma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed